Financing and global licensing deal to accelerate phase 2b development of AP306 R1 Therapeutics has launched with an oversubscribed $77.5 million Series A financing and an exclusive global licence to ...
R1 Therapeutics is debuting with an oversubscribed $77.5 million series A financing aimed at advancing its first-in-class therapy for chronic kidney disease (CKD) patients on dialysis with high ...
Rivian is gearing up to launch the highly anticipated R2 on March 12, but it looks like they’re also planning to trim the R1 lineup. This is unfortunate, but the company sent out a rather ominous ...
Series A co-led by Abingworth, DaVita Venture Group, and F-Prime with participation from Curie.Bio, SymBiosis, and U.S. Renal Care Partnership with Alebund Pharmaceuticals to gain exclusive global ...
REDWOOD CITY, Calif., March 17, 2026 (GLOBE NEWSWIRE)-- R1 Therapeutics, Inc (“R1”), a clinical-stage biopharmaceutical company focused on the development of first-in-class therapies for patients with ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company looks to grow from ...
Gaming PCs This AMD RX 9070 XT and 7800X3D gaming PC is somehow beating last year's prices at $1,750 Handheld Gaming PCs Best handheld gaming PC in 2026: my recommendations for the best portable ...
Hosted on MSN
R1 Therapeutics launches with $78 million funding round, secures kidney disorder treatment license
March 17 (Reuters) - R1 Therapeutics said on Tuesday it had launched operations with a $77.5 million Series A funding round and an exclusive license to develop and commercialize a drug for high ...
Rivian plans to discontinue the entry trims of the R1S SUV and R1T pickup this year, the startup said on Tuesday. "Dual Standard is ending," Rivian said in a marketing email. "We have changes coming ...
The University of Texas at San Antonio today announced its R1 Classification from the Carnegie Classification of Institutions of Higher Education is now official. Yesterday marked the end of ...
There is no recent news for this security. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results